Medifast Inc Stock

$14.40

1.91% day before yesterday

NYSE, Jul 11, 10:10 pm CET

ISIN

US58470H1014

Symbol

MED

Reports

Quarter | Annual

Index

NYSE Composite

Overview Dividends Analysts Charts News Strategies

Medifast Inc Stock price

$14.40

-137.08 90.49% 5Y

NYSE, Closing price Fri, Jul 11 2025

-0.28 1.91%

ISIN

US58470H1014

Symbol

MED

Reports

Quarter | Annual

Index

NYSE Composite

Key metrics

Basic

Market capitalization

$158.3m

Enterprise Value

$-6.3m

Net debt

positive

Cash

$164.6m

Shares outstanding

11.0m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

0.3 | 0.4

EV/Sales

negative | negative

EV/FCF

negative

P/B

0.8

Dividends

DPS

$0.00

Yield 1Y | 5Y

0.0% | 3.4%

Growth 1Y | 5Y

-100.0% | -100.0%

Payout 1Y | 3Y

0.0% | 52.3%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$543.5m | $394.0m

EBITDA

$12.3m | $-5.7m

EBIT

$-396.0k | $-17.4m

Net Income

$-7.0m | $-11.1m

Free Cash Flow

$13.5m

Growth (TTM | estimate)

Revenue

-39.5% | -34.6%

EBITDA

-86.9% | -117.6%

EBIT

-100.5% | -189.2%

Net Income

-110.3% | -631.1%

Free Cash Flow

-84.1%

Financial Health

Equity Ratio

73.9%

Return on Equity

1.0%

ROCE

-0.2%

ROIC

-0.6%

Debt/Equity

0.0

EPS

$-0.6

FCF per Share

$1.2

Short interest

15.4%

Employees

504

Rev per Employee

$1.2m

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Medifast Inc Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Medifast Inc forecast:

3x Hold

38%

5x Sell

63%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Medifast Inc forecast:

Hold

38%

Sell

63%

Analyst Estimates with Stock Price Targets

Financial data from Medifast Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	543 543	39% 39% 100%
- Direct Costs	142 142	41% 41% 26%
Gross Profit	402 402	39% 39% 74%
- Selling and Administrative Expenses	385 385	33% 33% 71%
- Research and Development Expense	4.50 4.50	2% 2% 1%
EBITDA	12 12	87% 87% 2%
- Depreciation and Amortization	13 13	5% 5% 2%
EBIT (Operating Income) EBIT	-0.40 -0.40	100% 100% 0%
Net Profit	-7 -7	110% 110% -1%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Medifast Inc Stock News

Positive

Seeking Alpha

●

10 days ago

Medifast: Coach Surge Fuels Growth

Initiate Medifast with Strong Buy and $56 PT, citing overlooked operational inflection and coach network momentum driving above-consensus FY26 revenue growth. ASCEND product line and digital engagement tools are key catalysts, improving client retention, coach productivity, and setting the stage for a top line comeback. Valuation is anchored on a conservative 1.3x forward P/S multiple, offering...

Neutral

Seeking Alpha

●

3 months ago

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney - Chief Financial Officer Nick Johnson - Chief Field Operations Officer Conference Call Participants Jim Salera - Stephens Doug Lane - Water Tower Research Operator Greetings. And welcome to the Med...

Neutral

Business Wire

●

3 months ago

Medifast Announces First Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, wh...

More Medifast Inc News

Company Profile

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD

Head office	United States
CEO	Daniel Chard
Employees	504
Founded	1981
Website	medifastinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now